Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-10
1991-07-09
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514912, A61K 3144
Patent
active
050306375
ABSTRACT:
A method is disclosed for the prevention and alleviation of pathologic changes in the eye such as diabetic retinopathy or senile macular degeneration. The claimed method involves the parenteral administration of anisodamine in an amount effective for preventing or alleviating these pathogenic changes.
REFERENCES:
Chem. Abst., 110:226915d, (1989), Li et al.
S. Zhang et al., Pediatric Res. 20,177a, (1986).
Pharmacologic Effects of Anisodamine, Chines Med. J., 7, 133-138, (1975).
Fed. Proc., vol. 23, 4, Part 2, May 1988, p. 882.
Einzig Stanley
Zhang Shu-Lun
Fay Zohyeh A.
Friedman Stanley J.
Regents of the University of Minnesota
LandOfFree
Anisodamine to prevent and treat eye disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anisodamine to prevent and treat eye disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anisodamine to prevent and treat eye disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-618394